title: Combination of betamethasone and methotrexate for the treatment of scleromyxoedema without paraproteinaemia.
authors.affiliation: Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing 210042, China.
authors.forename: Xiu-Lian
authors.initials: XL
authors.lastname: Xu
authors.affiliation: Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing 210042, China.
authors.forename: Qiong
authors.initials: Q
authors.lastname: Wu
authors.affiliation: Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing 210042, China.
authors.forename: Xue-Si
authors.initials: XS
authors.lastname: Zeng
authors.affiliation: Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing 210042, China.
authors.forename: Jian-Fang
authors.initials: JF
authors.lastname: Sun
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D053718:Scleromyxedema / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D001623:Betamethasone; D008727:Methotrexate